Delta-9-THC
Delta-9-THC is a pharmaceutical drug with 7 clinical trials. Currently 1 active trials ongoing. Historical success rate of 83.3%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
6
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 1Trial Status & Enrollment
83.3%
5 of 6 finished
16.7%
1 ended early
1
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
High Confusion: Cannabis & Driving
Delta-8-THC vs. Delta-9-THC on Simulated Driving Performance
Behavioral Pharmacology of Orally Administered THC and D-limonene
Does Cannabidiol Attenuate the Acute Effects of ∆9-tetrahydrocannabinol Intoxication in Individuals Diagnosed With Schizophrenia? A Double-blind, Randomised, Placebo-controlled Experimental Study
The Effects of ∆-9-THC and Naloxone in Humans
Clinical Trials (7)
High Confusion: Cannabis & Driving
Delta-8-THC vs. Delta-9-THC on Simulated Driving Performance
Behavioral Pharmacology of Orally Administered THC and D-limonene
Does Cannabidiol Attenuate the Acute Effects of ∆9-tetrahydrocannabinol Intoxication in Individuals Diagnosed With Schizophrenia? A Double-blind, Randomised, Placebo-controlled Experimental Study
The Effects of ∆-9-THC and Naloxone in Humans
N-acetylcysteine Effects on Tetrahydrocannabinol
The Effects of Cannabidiol and ∆-9-THC in Humans
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7